Skip to main content
SpringerLink
Log in

Risk Factors for Nodal Recurrence After Lymphadenectomy for Melanoma

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background:The risk and outcome of regional failure after elective and therapeutic lymph node dissection (ELND/TLND) for microscopically and macroscopically involved lymph nodes without adjuvant radiotherapy were evaluated.

Methods:Retrospective melanoma database review of 338 patients (ELND 85, TLND 253) from 1970 to 1996 with pathologically involved lymph nodes.

Results:Regional recurrence occurred in 14% of patients treated with ELND (n = 12) and 28% of patients treated with TLND (n = 72; P = .009). Risk factors associated with nodal recurrence were advanced age, primary lesion in the head and neck region, depth of the primary lesion, number of involved lymph nodes, and extracapsular extension (ECE). For each nodal basin, the ELND group had a lower incidence of recurrence than the TLND group. The TLND group had larger lymph nodes, greater number of involved lymph nodes, and a higher incidence of ECE. The 10-year disease-specific survival was 51% vs. 30% for ELND and TLND, respectively (P = .0005). Nodal basin failure was predictive of distant metastasis, with 87% developing distant disease compared with 54% of patients without nodal recurrence (P < .0001). Of six patients who underwent a second dissection after isolated nodal recurrence, five patients have had a median disease-free interval of 79 months.

Conclusions:After ELND or TLND, patients who have a large tumor burden (thick primary melanoma, multiply involved lymph nodes, ECE), advanced age, and a primary lesion located in the head and neck have a significantly increased likelihood of relapse and a decreased survival. Few patients present with an isolated nodal recurrence, but the majority can be salvaged by a second dissection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Fusi S, Ariyan S, Sternlicht A. Data on first recurrence after treatment for malignant melanoma in a large patient population Plast Reconstr Surg 1993; 91: 94–8.

    Google Scholar 

  2. Reintgen DS, Cox C, Slingluff CL, Seigler HF. Recurrent melanoma: The identification of prognostic factors to predict survival. Ann Plast Surg 1992; 28: 45–9.

    Google Scholar 

  3. McCarthy WH, Shaw HM, Thompson JF, Milton GW. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow up study. Surg Gynecol Obstet 1988; 166: 497–502.

    Google Scholar 

  4. Milton GW, Shaw HM, Farago GA, McCarthy WH. Tumor thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I). Br J Surg 1980; 67: 543–6.

    Google Scholar 

  5. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996; 224: 25–66.

    Google Scholar 

  6. Balch CM, Soong SJ, Ross MI, et al. Long term results of a multi-institutional randomized trial comparing prognostic factor and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Ann Surg Oncol 2000; 7: 87–97.

    Google Scholar 

  7. Emilia J, Lawrence W. Sentinel lymph node biopsy in malignant melanoma: The standard of care? J Surg Oncol 1997; 65: 153–4.

    Google Scholar 

  8. Miller EJ, Daly JM, Synnestvedt M, Schultz D, Elder D, Guerry D. Loco-regional nodal relapse in melanoma. Surg Oncol 1992; 1: 333–40.

    Google Scholar 

  9. Warso MA, DasGupta TK. Melanoma recurrence in a previously dissected lymph node basin. Arch Surg 1994; 129: 252–5.

    Google Scholar 

  10. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989; 124: 1051–5.

    Google Scholar 

  11. Monsour PD, Sause WT, Avent JM, Noyes RD. Local control following therapeutic nodal dissection for melanoma. J Surg Oncol 1993; 54: 18–22.

    Google Scholar 

  12. Ang KK, Peters LJ, Weber RS, et al. Post operative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys 1994; 30: 795–8.

    Google Scholar 

  13. Karakousis CP, Driscoll DL, Rose B, Walsh DL. Groin dissection in malignant melanoma. Ann Surg Oncol 1994; 1: 271–7.

    Google Scholar 

  14. Karakousis CP. Therapeutic node dissections in malignant melanoma. Ann Surg Oncol 1998; 5: 473–82.

    Google Scholar 

  15. Cox D. Regression models and life tables. J Royal Stat Soc B 1972; 34: 187–220.

    Google Scholar 

  16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.

    Google Scholar 

  17. Show JHF, Rumball EM. Complications and local recurrence following lymphadenectomy. Br J Surg 1990; 77: 760–4.

    Google Scholar 

  18. Gadd MA, Coit DG. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg 1992; 127: 1412–6.

    Google Scholar 

  19. O’Brien CJ, Gianoutsos MP, Morgan MJ. Neck dissection for cutaneous malignant melanoma. World J Surg 1992; 16: 222–6.

    Google Scholar 

  20. Belli F, Nave M, Santinami M, Rovini D, Valgani M. Management of nodal metastases from head and neck melanoma. J Surg Oncol 1989; 42: 47–53.

    Google Scholar 

  21. Baas PC, Koops HS, Hoekstra HJ, van Bruggen JJ, van derWheele LT, Oldhoff J. Groin dissection in the treatment of lower-extremity melanoma. Arch Surg 1992; 127: 281–6.

    Google Scholar 

  22. Van deVrie W, Eggermont AMM, Was Putten WLJ, Wiggers T. Therapeutic lymphadenectomy in melanomas of the head and neck. Head Neck 1993; 15: 377–81.

    Google Scholar 

  23. Mann GB, Coit DC. Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol 1999; 6: 263–71.

    Google Scholar 

  24. Strom EA, Ross MI. Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: Toxicity and local control. Ann Surg Oncol 1995; 2: 445–9.

    Google Scholar 

  25. O’Brian CJ, Petersen-Schaefer K, Ruark D, Coates AS, Menzie SJ, Harrison RI. Radical, modified and selective neck dissection for cutaneous malignant melanoma. Head Neck 1995; 17: 232–41.

    Google Scholar 

  26. Johanson CR, Harwood AR, Cummings BJ, Ouirt I. 0-7-21 radiotherapy in nodular melanoma. Cancer 1983; 51: 226–32.

    Google Scholar 

  27. Houghton A, Coit D, Bloomer W, et al. NCCN melanoma practice guidelines. National Comprehensive Cancer Network. Oncology 1998; 12: 153–177.

    Google Scholar 

  28. Essner R, Conforti AC, Kelley MC, Wanek L, Stern A, Glass E, Morton DL. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999; 6: 442–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Roswell Park Cancer Institute, State University of New York, Buffalo, New York

    Ihor Pidhorecky MD, Daniel R. Kollmorgen MD, Deborah L. Driscoll BA, William G. Kraybill MD & John F. Gibbs MD

  2. Division of Radiation Medicine, Roswell Park Cancer Institute, State University of New York, Buffalo, New York

    R. Jeffrey Lee MD, Gary Proulx MD & Chaoying Jia MD

  3. Division of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY, 14263

    John F. Gibbs MD

Authors
  1. Ihor Pidhorecky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Jeffrey Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gary Proulx MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel R. Kollmorgen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chaoying Jia MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Deborah L. Driscoll BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. William G. Kraybill MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. John F. Gibbs MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John F. Gibbs MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pidhorecky, I., Lee, R.J., Proulx, G. et al. Risk Factors for Nodal Recurrence After Lymphadenectomy for Melanoma. Ann Surg Oncol 8, 109–115 (2001). https://doi.org/10.1007/s10434-001-0109-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-001-0109-2

Key Words

Search

Navigation